RAPID MICRO BIOSYSTEMS, INC.
NASDAQ: RPID. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:97955e74-ff1c-4271-8601-2f30ddd6b9c5
- SEC CIK
- 0001380106
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 17, 2026
- Newest evidence
- Apr 8, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Robert SpignesiSince Apr 8, 2026
- Chair
- Not published
- Independent
- 6 / 77 directors published
- Published claims
- 242 distinct sources
- Evidence records
- 60 pinned
- Source conflicts
- 0None open
Built from 2 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
John Wilson executive of RAPID MICRO BIOSYSTEMS, INC., effective 2026-04-08.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Operating Officer | John Wilson | Apr 2026 | current | Source reportedE3 |
| President and Chief Executive Officer and Director | Robert Spignesi | Apr 2026 | current | Source reportedE4 |
| Chief Financial Officer | Sean Wirtjes | Apr 2026 | current | Source reportedE5 |
Board of directors
Evidence7 directors published. 6 of 7 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Dafni Bika, Ph.D. | Independent | 2025 | None published | Source reportedE2 |
| Inese Lowenstein | Independent | 2021 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Kirk D. Malloy, Ph.D. | Independent | 2023 | None published | Source reportedE2 |
| Melinda Litherland | Independent | 2021 | Audit, chairAudit · Chair | Source reportedE2 |
| Natale Ricciardi | Independent | 2016 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Richard Kollender | Independent | 2009 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE2 |
| Robert Spignesi | Not independent | 2014 | None published | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Melinda Litherland | Melinda Litherland, Richard Kollender | Not described in the published record |
| Audit · Chair | Not published | Melinda Litherland | Not described in the published record |
| Audit; Nominating and Governance · Chair | Not published | Richard Kollender | Not described in the published record |
| Compensation | Not published | Inese Lowenstein, Natale Ricciardi | Not described in the published record |
| Compensation; Nominating and Governance | Not published | Inese Lowenstein, Natale Ricciardi | Not described in the published record |
| Nominating and Governance | Richard Kollender | Richard Kollender, Inese Lowenstein, Natale Ricciardi | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
EvidenceGovernance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- John WilsonChief Operating Officercompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:12
- Robert SpignesiPresident and Chief Executive Officer and Directorcompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:13, company:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:11
- Sean WirtjesChief Financial Officercompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:14
- Dafni Bika, Ph.D.Directorcompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:5
- Inese LowensteinDirectorcompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:6
- Kirk D. Malloy, Ph.D.Directorcompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:7
- Melinda LitherlandDirectorcompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:8
- Natale RicciardiDirectorcompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:9
- Richard KollenderDirectorcompany:97955e74-ff1c-4271-8601-2f30ddd6b9c5:leadership_role:10
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 6 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 17, 2026. Cited by 4 Claims.
- E2sec proxy. Published Apr 8, 2026. Retrieved Apr 24, 2026. Cited by 7 Claims.
- E3sec filing. Published Apr 8, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E4sec filing. Published Apr 8, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E5sec filing. Published Apr 8, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E6board_seats. board seats. Cited by 10 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 17, 2026- John Wilson executive of RAPID MICRO BIOSYSTEMS, INC., effective 2026-04-08.
- Robert Spignesi executive of RAPID MICRO BIOSYSTEMS, INC., effective 2026-04-08.
- Sean Wirtjes executive of RAPID MICRO BIOSYSTEMS, INC., effective 2026-04-08.
- Dafni Bika, Ph.D. seat on RAPID MICRO BIOSYSTEMS, INC., effective 2025-01-01.
- Kirk D. Malloy, Ph.D. seat on RAPID MICRO BIOSYSTEMS, INC., effective 2023-01-01.
- Inese Lowenstein seat on RAPID MICRO BIOSYSTEMS, INC., effective 2021-01-01.
- Melinda Litherland seat on RAPID MICRO BIOSYSTEMS, INC., effective 2021-01-01.
- Audit · Chair committee of RAPID MICRO BIOSYSTEMS, INC., effective 2021-01-01.
- Melinda Litherland member of Audit · Chair, effective 2021-01-01.
- Compensation; Nominating and Governance committee of RAPID MICRO BIOSYSTEMS, INC., effective 2021-01-01.
- Inese Lowenstein member of Compensation; Nominating and Governance, effective 2021-01-01.
- Natale Ricciardi seat on RAPID MICRO BIOSYSTEMS, INC., effective 2016-01-01.
- Natale Ricciardi member of Compensation; Nominating and Governance, effective 2016-01-01.
- Robert Spignesi seat on RAPID MICRO BIOSYSTEMS, INC., effective 2014-01-01.
- Richard Kollender seat on RAPID MICRO BIOSYSTEMS, INC., effective 2009-01-01.
- Audit; Nominating and Governance · Chair committee of RAPID MICRO BIOSYSTEMS, INC., effective 2009-01-01.
- Richard Kollender member of Audit; Nominating and Governance · Chair, effective 2009-01-01.

